Summary by Moomoo AI
Arcutis Biotherapeutics Officer Burnett Patrick plans to sell 16,023 common shares on 11/22/2024. The shares were acquired through a stock option exercise on 01/12/2024, with a total market value of approximately $162,515. The transaction will be completed with a cash payment.In the past 3 months, Arcutis Biotherapeutics has seen significant stock activity, with a total of 84,667 shares sold, generating gross proceeds of $846,243. Notable transactions include sales on 11/04/2024 and 11/14/2024, with the latter date seeing two separate transactions totaling 69,126 shares.This announcement provides investors with insight into the ongoing stock transactions by company insiders, reflecting potential strategic financial decisions.
